Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Valvular heart disease is common in cancer patients but interventions improve survival
Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat…
Keeping the heart healthy increases longevity even after cancer
Being more physically active, following a balanced diet, not smoking, and keeping body weight and…
New gene-mapping method unlocks hidden drivers of cancer
University of South Australia scientists have developed a powerful new way to uncover the genetic…
ChatGPT: Will it revolutionise cancer patient information? Part 2
Did you know Artificial Intelligence can pass medical school entrance exams? How will ChatGPT revolutionise the way patients find healthcare…
ASCO 2025: Molecular assay may help identify people with NSCLC who could benefit from adjuvant chemotherapy
- ASCO 2025: Addition of lurbinectedin to first-line maintenance treatment for small cell lung cancer prolongs survival, according to phase 3 trial
- Relationship between mutation profile detected by next-generation sequencing and histopathological parameters in lung squamous cell carcinoma
- Immune checkpoint inhibitors significantly increase myocarditis risk in NSCLC patients
Poor, middle-aged Australians are more likely to die from cancer – and the gap is widening
Kadir Atalay, University of Sydney and Rebecca Edwards, University of Sydney A cancer diagnosis is frightening news for anyone. But…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.